TY - BOOK PY - 2013 DA - 2013// TI - Global Polio Eradication Initiative: Polio Eradication and Endgame Strategic Plan (2013–2018) PB - Report number: WHO/POLIO/13.02 CY - Geneva ID - ref1 ER - TY - STD TI - Global Polio Eradication Initiative; World ready for OPV2 cessation [http://www.polioeradication.org/mediaroom/newsstories/World-ready-for-OPV2-cessation-/tabid/526/news/1181/Default.aspx?popUp=true, Accessed 28 Jan 2015] UR - http://www.polioeradication.org/mediaroom/newsstories/World-ready-for-OPV2-cessation-/tabid/526/news/1181/Default.aspx?popUp=true ID - ref2 ER - TY - JOUR AU - Thompson, K. M. AU - Duintjer Tebbens, R. J. PY - 2014 DA - 2014// TI - Modeling the dynamics of oral poliovirus vaccine cessation JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit845 DO - 10.1093/infdis/jit845 ID - Thompson2014 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Cochi, S. L. AU - Wassilak, S. G. F. AU - Thompson, K. M. PY - 2015 DA - 2015// TI - An economic analysis of poliovirus risk management policy options for 2013–2052 JO - BMC Infect Dis VL - 15 UR - https://doi.org/10.1186/s12879-015-1112-8 DO - 10.1186/s12879-015-1112-8 ID - Duintjer Tebbens2015 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Thompson, K. M. PY - 2015 DA - 2015// TI - Managing the risk of circulating vaccine-derived poliovirus during the endgame: Oral poliovirus vaccine needs JO - BMC Infect Dis VL - 15 UR - https://doi.org/10.1186/s12879-015-1114-6 DO - 10.1186/s12879-015-1114-6 ID - Duintjer Tebbens2015 ER - TY - STD TI - Global Polio Eradication Initiative; Operational Framework for Monovalent Oral Poliovirus Type 2 (mOPV2) deployment and replenishment (during the endgame period) [http://www.polioeradication.org/Portals/0/Document/Resources/PostEradication/mOPV2_Operational_Framework.pdf, Accessed 25 Sept 2015] UR - http://www.polioeradication.org/Portals/0/Document/Resources/PostEradication/mOPV2_Operational_Framework.pdf ID - ref6 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Wassilak, S. G. F. AU - Cochi, S. L. AU - Thompson, K. M. PY - 2016 DA - 2016// TI - Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame JO - BMC Infect Dis VL - 16 UR - https://doi.org/10.1186/s12879-016-1465-7 DO - 10.1186/s12879-016-1465-7 ID - Duintjer Tebbens2016 ER - TY - JOUR PY - 2015 DA - 2015// TI - Introduction of inactivated poliovirus vaccine and switch from trivalent to bivalent oral poliovirus vaccine – worldwide, 2013–2016 JO - MMWR Morb Mortal Wkly Rep VL - 64 ID - ref8 ER - TY - JOUR AU - Kalkowska, D. A. AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Cochi, S. L. AU - Wassilak, S. G. F. AU - Thompson, K. M. PY - 2015 DA - 2015// TI - Modeling undetected live poliovirus circulation after apparent interruption of transmission: Implications for surveillance and vaccination JO - BMC Infect Dis VL - 15 ID - Kalkowska2015 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Thompson, K. M. PY - 2014 DA - 2014// TI - Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit838 DO - 10.1093/infdis/jit838 ID - Duintjer Tebbens2014 ER - TY - JOUR AU - Hird, T. R. AU - Grassly, N. C. PY - 2012 DA - 2012// TI - Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge JO - PLoS Pathog VL - 8 UR - https://doi.org/10.1371/journal.ppat.1002599 DO - 10.1371/journal.ppat.1002599 ID - Hird2012 ER - TY - STD TI - Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Expert review on poliovirus immunity and transmission. Risk Anal. 2013;33(4):544–605. ID - ref12 ER - TY - STD TI - Anis E, Kopel E, Singer S, Kaliner E, Moerman L, Moran-Gilad J, Sofer D, Manor Y, Shulman L, Mendelson E et al.: Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill. 2013, 18(38). ID - ref13 ER - TY - STD TI - Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SGF, et al. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. J Infect Dis. 2015;211(11):1800–12. ID - ref14 ER - TY - JOUR AU - Thompson, K. M. AU - Kalkowska, D. A. AU - Duintjer Tebbens, R. J. PY - 2015 DA - 2015// TI - Managing population immunity to reduce or eliminate the risks of circulation following the importation of live polioviruses JO - Vaccine VL - 33 UR - https://doi.org/10.1016/j.vaccine.2015.02.013 DO - 10.1016/j.vaccine.2015.02.013 ID - Thompson2015 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Kalkowska, D. A. AU - Wassilak, S. G. AU - Cochi, S. L. AU - Thompson, K. M. PY - 2013 DA - 2013// TI - Characterizing poliovirus transmission and evolution: Insights from modeling experiences with wild and vaccine-related polioviruses JO - Risk Anal VL - 23 UR - https://doi.org/10.1111/risa.12044 DO - 10.1111/risa.12044 ID - Duintjer Tebbens2013 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Kalkowska, D. A. AU - Wassilak, S. G. F. AU - Pallansch, M. A. AU - Cochi, S. L. AU - Thompson, K. M. PY - 2014 DA - 2014// TI - The potential impact of expanding target age groups for polio immunization campaigns JO - BMC Infect Dis VL - 14 UR - https://doi.org/10.1186/1471-2334-14-45 DO - 10.1186/1471-2334-14-45 ID - Duintjer Tebbens2014 ER - TY - STD TI - Duintjer Tebbens RJ, Pallansch MA, Chumakov KM, Halsey NA, Hovi T, Minor PD, et al. Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs. Risk Anal. 2013;33(4):606–46. ID - ref18 ER - TY - STD TI - Duintjer Tebbens RJ, Pallansch MA, Kim J-H, Burns CC, Kew OM, Oberste MS, et al. Review: Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs). Risk Anal. 2013;23(4):680–702. ID - ref19 ER - TY - BOOK AU - Anderson, R. M. AU - May, R. M. PY - 1991 DA - 1991// TI - Infectious diseases of humans: dynamics and control PB - Oxford University Press CY - New York ID - Anderson1991 ER - TY - JOUR AU - Thompson, K. M. AU - Pallansch, M. A. AU - Duintjer Tebbens, R. J. AU - Wassilak, S. G. F. AU - Cochi, S. L. PY - 2013 DA - 2013// TI - Modeling population immunity to support efforts to end the transmission of live polioviruses JO - Risk Anal VL - 33 UR - https://doi.org/10.1111/j.1539-6924.2012.01891.x DO - 10.1111/j.1539-6924.2012.01891.x ID - Thompson2013 ER - TY - JOUR AU - Kalkowska, D. A. AU - Duintjer Tebbens, R. J. AU - Thompson, K. M. PY - 2014 DA - 2014// TI - Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit834 DO - 10.1093/infdis/jit834 ID - Kalkowska2014 ER - TY - STD TI - World Bank; World Bank list of economies (October 2013) [http://siteresources.worldbank.org/DATASTATISTICS/Resources/CLASS.XLS, Accessed 23 Dec 2013] UR - http://siteresources.worldbank.org/DATASTATISTICS/Resources/CLASS.XLS ID - ref23 ER - TY - JOUR AU - Duintjer Tebbens, R. J. AU - Pallansch, M. A. AU - Thompson, K. M. PY - 2015 DA - 2015// TI - Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs JO - BMC Infect Dis VL - 15 UR - https://doi.org/10.1186/s12879-015-1115-5 DO - 10.1186/s12879-015-1115-5 ID - Duintjer Tebbens2015 ER - TY - JOUR AU - Kalkowska, D. A. AU - Duintjer Tebbens, R. J. AU - Thompson, K. M. PY - 2014 DA - 2014// TI - Modeling strategies to increase population immunity and prevent poliovirus transmission in two high-risk areas in northern India JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jit844 DO - 10.1093/infdis/jit844 ID - Kalkowska2014 ER - TY - STD TI - World Health Organization; Global Polio Eradication Initiative -- circulating vaccine-derived poliovirus cases 2000–2015 [http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Circulatingvaccinederivedpoliovirus.aspx, Accessed 5 Aug 2015] UR - http://www.polioeradication.org/Dataandmonitoring/Poliothisweek/Circulatingvaccinederivedpoliovirus.aspx ID - ref26 ER - TY - JOUR AU - Thompson, K. M. AU - Duintjer Tebbens, R. J. PY - 2008 DA - 2008// TI - The case for cooperation in managing and maintaining the end of poliomyelitis: Stockpile needs and coordinated OPV cessation JO - Medscape J Med VL - 10 ID - Thompson2008 ER - TY - JOUR AU - Barrett, S. PY - 2009 DA - 2009// TI - Polio eradication: Strengthening the weakest links JO - Health Affairs VL - 28 UR - https://doi.org/10.1377/hlthaff.28.4.1079 DO - 10.1377/hlthaff.28.4.1079 ID - Barrett2009 ER - TY - STD TI - Chen RT, Hausinger S, Dajani AS, Hanfling M, Baughman AL, Pallansch MA, et al. Seroprevalence of antibody against poliovirus in inner-city preschool children. JAMA. 1996;275(21):1639–45. ID - ref29 ER - TY - STD TI - Más Lago P, Bravo JR, Andrus JK, Comellas MM, Galindo MA, de Quadros CA, et al. Lesson from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Bull World Health Organ. 1994;72(2):221–5. ID - ref30 ER - TY - JOUR PY - 1996 DA - 1996// TI - Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines JO - Bull World Health Organ VL - 74 ID - ref31 ER - TY - BOOK PY - 2005 DA - 2005// TI - Polio Eradication Initiative. Cessation of Routine Oral Polio Vaccine (OPV) use after Global Polio Eradication PB - Report number: WHO/POL/05.02 CY - Geneva ID - ref32 ER - TY - STD TI - Duintjer Tebbens RJ, Hampton LM, Thompson KM: Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: Risks of inadvertent trivalent oral poliovirus vaccine use. 2016;16. doi:10.1186/s12879-016-1537-8. (In press) ID - ref33 ER - TY - STD TI - El-Sayed N, El-Gamal Y, Abbassy AA, Seoud I, Salama M, Kandeel A, et al. Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med. 2008;359(16):1655–65. ID - ref34 ER -